C7B.1

Clinical Causes: Initial development of Merkel cell carcinoma, typically caused by sun exposure and aging. Spread of the primary tumor to nearby lymph nodes or distant organs. Weakened immune system, which may be due to factors like immunosuppressive therapy, HIV/AIDS, or other immunodeficiency conditions. Presence of Merkel cell polyomavirus, a virus linked to the development of MCC. Genetic predispositions that may increase susceptibility.

Key Symptoms: Swollen or enlarged lymph nodes, particularly in regions near the original tumor. Persistent or growing skin lesions, often firm, painless, and rapidly enlarging. Signs of metastasis in internal organs can include organ-specific symptoms, such as respiratory issues if lungs are involved. General symptoms such as fatigue, weight loss, or fever if the disease has spread extensively. Sometimes, nodal or visceral metastasis presents without skin lesions, making diagnosis more complex.

Diagnosis Path: Diagnosing secondary Merkel cell carcinoma involves a combination of clinical examination, imaging studies, and laboratory tests. Procedures such as lymph node biopsies and tissue analysis help confirm metastasis. Imaging tools like CT scans, PET scans, or MRI are used to identify internal organ involvement. Pathology confirms MCC through the examination of tissue samples, often aided by immunohistochemistry.

Treatment Protocols: Chemotherapy to target cancer cells throughout the body. Immunotherapy options, such as immune checkpoint inhibitors, which have shown promising results for MCC. Radiation therapy to alleviate symptoms or control localized disease within lymph nodes or specific sites. Surgical removal of accessible metastases or affected lymph nodes in some cases. Supportive care to improve quality of life, manage symptoms, and address complications.